Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 92290 Châtenay-Malabry, France.
Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 92290 Châtenay-Malabry, France.
Adv Drug Deliv Rev. 2019 Jan 1;138:167-192. doi: 10.1016/j.addr.2018.10.005. Epub 2018 Oct 11.
Polymer nanocarriers allow drug encapsulation leading to fragile molecule protection from early degradation/metabolization, increased solubility of poorly soluble drugs and improved plasmatic half-life. However, efficiently controlling the drug release from nanocarriers is still challenging. Thermoresponsive polymers exhibiting either a lower critical solution temperature (LCST) or an upper critical solution temperature (UCST) in aqueous medium may be the key to build spatially and temporally controlled drug delivery systems. In this review, we provide an overview of LCST and UCST polymers used as building blocks for thermoresponsive nanocarriers for biomedical applications. Recent nanocarriers based on thermoresponsive polymer exhibiting unprecedented features useful for biomedical applications are also discussed. While LCST nanocarriers have been studied for over two decades, UCST nanocarriers have recently emerged and already show great potential for effective thermoresponsive drug release.
聚合物纳米载体允许药物包封,从而保护脆弱的分子免受早期降解/代谢,增加难溶性药物的溶解度,并延长血浆半衰期。然而,有效地控制纳米载体中药物的释放仍然具有挑战性。在水介质中表现出较低临界溶液温度 (LCST) 或较高临界溶液温度 (UCST) 的温敏聚合物可能是构建空间和时间控制药物递送系统的关键。在本综述中,我们概述了用于生物医学应用的温敏纳米载体的 LCST 和 UCST 聚合物作为构建块。还讨论了基于温敏聚合物的最近的纳米载体,它们具有用于生物医学应用的前所未有的有用特性。虽然 LCST 纳米载体已经研究了二十多年,但 UCST 纳米载体最近才出现,并且已经显示出有效控制温敏药物释放的巨大潜力。
Adv Drug Deliv Rev. 2018-10-11
Beilstein J Org Chem. 2021-8-20
Macromol Rapid Commun. 2021-4
ACS Appl Mater Interfaces. 2016-8-11
Angew Chem Int Ed Engl. 2015-1-28
Int J Mol Sci. 2025-7-29
Front Pharmacol. 2025-7-28
Acta Epileptol. 2024-7-23
Macromolecules. 2025-2-26
Front Immunol. 2025-1-23